|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT00770289 |
|
Date of registration:
|
08/10/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)
B2411003 |
|
Scientific title:
|
Open Label, Observational, Non-interventional Study for the Evaluation of Remission Rates in Patients With MDD Under Treatment With Various Anti-depressives |
|
Date of first enrolment:
|
May 2008 |
|
Target sample size:
|
851 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT00770289 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Greece
| | | | | | | |
|
Contacts
|
|
Name:
|
Pfizer CT.gov Call Center |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Pfizer |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Outpatients
- 18-75 years old
- Patients diagnosed with MDD according to DSM IV without psychotic symptoms
- HAM-D17 > or = 18 on inclusion
- Patients receiving treatment for the first time or changing treatment based on their
doctor's decision
Exclusion Criteria:
- Subjects with potentially problematic compliance
- Subjects participating in an interventional trial within the last 3 months
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Major Depressive Disorder
|
|
Intervention(s)
|
|
Other: Cohort
|
|
Primary Outcome(s)
|
|
Percentage of Participants With Remission Based on Hamilton Depression Scale (HAM-D)
[Time Frame: Week 12]
|
|
Secondary Outcome(s)
|
|
Number of Participants With Residual Symptoms in Case of Non Remission
[Time Frame: Week 12]
|
|
Hamilton Depression Scale 17 (HAM-D17), HAM-D7 and Beck Depression Inventory (BDI)
[Time Frame: Baseline, Week 12]
|
|
Percentage of Participants With Remission Based on Beck Depression Inventory (BDI)
[Time Frame: Week 12]
|
|
Secondary ID(s)
|
|
0600B-102374
|
|
B2411003
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|